Integrative genomic analysis identifies that SERPINA6-rs1998056 regulated by FOXA/ERα is associated with female hepatocellular carcinoma
- PMID: 25198130
- PMCID: PMC4157870
- DOI: 10.1371/journal.pone.0107246
Integrative genomic analysis identifies that SERPINA6-rs1998056 regulated by FOXA/ERα is associated with female hepatocellular carcinoma
Abstract
The human forkhead box A1 (FOXA1) and A2 (FOXA2) transcription factors have been found to control estrogen and androgen signaling through co-regulating target genes with sex hormone receptors. Here we used an integrative strategy to examine the hypothesis that genetic variants at FOXA1/2 binding elements may be associated with sexual dimorphism of hepatocellular carcinoma (HCC) risk. Firstly we extracted chromatin immunoprecipitation-sequencing (ChIP-seq) data of FOXA1, FOXA2 and estrogen receptor 1(ERα) from ENCODE database to obtain dual target regions of FOXA/ERα, and further intersected these regions with genes' promoters. Then we used MATCH program to predict FOXA binding elements, in which genetic variants were retrieved by dbSNP database (NCBI, build 134). A total of 15 candidate variants were identified in this stage. Secondly we performed a case-control study with 1,081 HCC patients and 2,008 matched controls and found a significant association of SERPINA6-rs1998056 with female HCC risk under common genetic models (e.g. GG versus CC: OR = 2.03, 95% CI = 1.26-3.27, P = 0.004). Moreover, results from our real-time quantitative polymerase chain reaction (qPCR) using 72 normal liver tissues adjacent to the tumors showed that SERPINA6 expression was significantly different among different genotypes of this variant (GG versus CC: P = 0.032; Group test: P = 0.060). In summary, our study suggested that SERPINA6-rs1998056 regulated by FOXA/ERα might be associated with female HCC risk.
Conflict of interest statement
Figures
Similar articles
-
Trans-acting non-synonymous variant of FOXA1 predisposes to hepatocellular carcinoma through modulating FOXA1-ERα transcriptional program and may have undergone natural selection.Carcinogenesis. 2020 Apr 22;41(2):146-158. doi: 10.1093/carcin/bgz136. Carcinogenesis. 2020. PMID: 31400761
-
Interplay of estrogen receptors and FOXA factors in the liver cancer.Mol Cell Endocrinol. 2015 Dec 15;418 Pt 3(0 3):334-9. doi: 10.1016/j.mce.2015.01.043. Epub 2015 Feb 4. Mol Cell Endocrinol. 2015. PMID: 25661537 Free PMC article. Review.
-
Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer.Cell. 2012 Jan 20;148(1-2):72-83. doi: 10.1016/j.cell.2011.11.026. Cell. 2012. PMID: 22265403 Free PMC article.
-
Negative regulation of hepatitis B virus replication by forkhead box protein A in human hepatoma cells.FEBS Lett. 2015 Apr 28;589(10):1112-8. doi: 10.1016/j.febslet.2015.03.022. Epub 2015 Mar 30. FEBS Lett. 2015. PMID: 25836733
-
Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies.Gene. 2019 Feb 15;685:143-148. doi: 10.1016/j.gene.2018.11.012. Epub 2018 Nov 4. Gene. 2019. PMID: 30403964 Review.
Cited by
-
Sexual Dimorphism in Glucocorticoid Stress Response.Int J Mol Sci. 2021 Mar 19;22(6):3139. doi: 10.3390/ijms22063139. Int J Mol Sci. 2021. PMID: 33808655 Free PMC article. Review.
-
The EndoC-βH1 cell line is a valid model of human beta cells and applicable for screenings to identify novel drug target candidates.Mol Metab. 2018 Feb;8:144-157. doi: 10.1016/j.molmet.2017.12.007. Epub 2017 Dec 19. Mol Metab. 2018. PMID: 29307512 Free PMC article.
-
The Estrogen Receptor α-Cistrome Beyond Breast Cancer.Mol Endocrinol. 2016 Oct;30(10):1046-1058. doi: 10.1210/me.2016-1062. Epub 2016 Aug 4. Mol Endocrinol. 2016. PMID: 27489947 Free PMC article. Review.
-
A phosphorylation-related variant ADD1-rs4963 modifies the risk of colorectal cancer.PLoS One. 2015 Mar 27;10(3):e0121485. doi: 10.1371/journal.pone.0121485. eCollection 2015. PLoS One. 2015. PMID: 25816007 Free PMC article.
References
-
- Jemal A, Bray F (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69–90. - PubMed
-
- Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893–2917. - PubMed
-
- Ming L, Thorgeirsson SS, Gail MH, Lu P, Harris CC, et al. (2002) Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China. Hepatology 36: 1214–1220. - PubMed
-
- El-Serag HB (2007) Epidemiology of hepatocellular carcinoma in USA. Hepatol Res 37 Suppl 2 S88–94. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous